Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Deletion of pcnB affects antibiotic susceptibility in resistant Escherichia coli by reducing copy number of ColE1-family plasmids

  • Wellner, Sandra marina
  • Fei, Xiao
  • Fresno Herrero, Ana
  • Olsen, John Elmerdahl
Plasmids play a major role in the spread of antibiotic resistance genes in bacteria. Plasmid copy number (PCN) is often tightly regulated. In plasmids of the ColE1-type, this regulation happens by a negative feedback mechanism using an antisense RNA. Here, we employed a sequencing-based method for determining PCN to demonstrate that copy number of different ColE1-family plasmids harboring antibiotic resistance genes increases during antibiotic treatment. Further, we show that deletion of the gene pcnB reduces the copy number of ColE1-family plasmids in E. coli MG1655, which in turn results in a reduced resistance to antimicrobials of the classes aminoglycosides, β-lactams and tetracyclines. In the absence of antibiotic selection, the deletion of pcnB also decreased the number of ColE1-type plasmids in a bacterial population. Hence, PcnB, which polyadenylates RNA, marking it for decay, represents a potential drug and helper-drug target that could be used to reduce PCN to re-sensitize bacteria with multi-copy-number resistance-plasmids to treatment with different antimicrobials.
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

Exploring Actinomycetes-derived natural products for activity against Streptococcus suis

  • Perez Falcón, Ayelén
  • Iorio, Marianna
  • Sosio, Margherita
  • Correa-Fiz, Florencia
  • Donadio, Stefano
  • Aragon, Virginia
Background Streptococcus suis is a major swine pathogen and an emerging zoonotic agent capable of causing severe systemic infections, leading to significant health and economic losses. In recent years, antimicrobial resistance in S. suis has increased substantially, with frequent reports of multidrug-resistant strains driven by extensive antimicrobial use in pig production. This situation is further exacerbated by the role of S. suis as a reservoir of resistance genes within a One Health context. Consequently, there is a growing need for new antimicrobial compounds. Actinomycetes represent a well-known source of bioactive compounds, and the exploration of rare and underexplored taxa offers opportunities to discover novel molecules with unique mechanisms of action. Methods A screening of 800 extracts derived from Actinomycetes was performed against two virulent S. suis strains to evaluate antimicrobial activity. Extracts showing inhibitory effects were further subjected to fractionation by chromatography to isolate and characterize active components. Subsequent analyses focused on identifying fractions with inhibitory activity against the target strains using high-resolution mass spectrometry. Results The initial screening identified numerous Actinomycetes-derived extracts with inhibitory activity against S. suis, including extracts with activity against one or both strains. Based on activity spectrum and taxonomic origin, nine extracts were selected for further analysis. Fractionation enabled the identification of active fractions with consistent inhibitory effects against both strains. Compound characterization revealed bioactive molecules related to verucopeptin, hydroxyrifamycin and thiopeptides. In one extract, the active compound could not be identified, with analysis suggesting a complex composition of its active fraction. Conclusions These findings support Actinomycetes as a valuable source of novel antimicrobials against S. suis. The identified bioactive molecules further emphasize the potential of underexplored microbes for the discovery and development of novel antimicrobials, especially relevant in the context of increasing antimicrobial resistance., This research and APF were funded by the European Union’s Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie Grant Agreement number 956154, as part of the Innovative Training Network (Innovative Approaches to Identification of Metabolic Targets for Antimicrobials [INNOTARGETS]) (https://cordis.europa.eu/project/id/956154). Extracts used for the screening were prepared under Grant Agreement no. 101000392 (MARBLES) funded by the European Union’s Horizon 2020 research and innovation Program, info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Exploring Actinomycetes-derived natural products for activity against Streptococcus suis

  • Perez Falcón, Ayelén
  • Iorio, Marianna
  • Sosio, Margherita
  • Correa-Fiz, Florencia
  • Donadio, Stefano
  • Aragon, Virginia
Background Streptococcus suis is a major swine pathogen and an emerging zoonotic agent capable of causing severe systemic infections, leading to significant health and economic losses. In recent years, antimicrobial resistance in S. suis has increased substantially, with frequent reports of multidrug-resistant strains driven by extensive antimicrobial use in pig production. This situation is further exacerbated by the role of S. suis as a reservoir of resistance genes within a One Health context. Consequently, there is a growing need for new antimicrobial compounds. Actinomycetes represent a well-known source of bioactive compounds, and the exploration of rare and underexplored taxa offers opportunities to discover novel molecules with unique mechanisms of action. Methods A screening of 800 extracts derived from Actinomycetes was performed against two virulent S. suis strains to evaluate antimicrobial activity. Extracts showing inhibitory effects were further subjected to fractionation by chromatography to isolate and characterize active components. Subsequent analyses focused on identifying fractions with inhibitory activity against the target strains using high-resolution mass spectrometry. Results The initial screening identified numerous Actinomycetes-derived extracts with inhibitory activity against S. suis, including extracts with activity against one or both strains. Based on activity spectrum and taxonomic origin, nine extracts were selected for further analysis. Fractionation enabled the identification of active fractions with consistent inhibitory effects against both strains. Compound characterization revealed bioactive molecules related to verucopeptin, hydroxyrifamycin and thiopeptides. In one extract, the active compound could not be identified, with analysis suggesting a complex composition of its active fraction. Conclusions These findings support Actinomycetes as a valuable source of novel antimicrobials against S. suis. The identified bioactive molecules further emphasize the potential of underexplored microbes for the discovery and development of novel antimicrobials, especially relevant in the context of increasing antimicrobial resistance., This research and APF were funded by the European Union’s Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie Grant Agreement number 956154, as part of the Innovative Training Network (Innovative Approaches to Identification of Metabolic Targets for Antimicrobials [INNOTARGETS]) (https://cordis.europa.eu/project/id/956154). Extracts used for the screening were prepared under Grant Agreement no. 101000392 (MARBLES) funded by the European Union’s Horizon 2020 research and innovation Program, info:eu-repo/semantics/publishedVersion